This randomized controlled trial evaluates the effect of acupressure application on cesareans' pain and the number of steps in the first mobilization. This study hypothesizes that acupressure reduces pain and improves number of steps.

Methods: In the study, 64 cesareans will randomly assigned to acupressure and placebo acupressure groups. To the acupressure group (n = 32), an average of 15 minutes will be applied to the LI4 (liver), P6 (pericardium) and the Sanyinjia points on the splenic meridian (SP6) located on the inner side of the lower leg, four fingers above the ankle and behind the tibia. In the placebo acupressure group (n = 32), the points 1.5 cm away from the LI4, P6 and SP6 points (four points in total) will be applied for an average of 15 minutes. The primary outcome of the research is the effect of acupressure on the pain of cesareans. The secondary outcome of the study is to determine the effect of acupressure on the number of steps. The pain will be collected before and 1 minute, 2nd and 4th hour after acupressure and placebo acupressure administration. The number of steps will be collected 4th hour after acupressure and placebo acupressure administration.

Inclusion Criteria:

• Being conscious,
• The mother tongue is Turkish,
• To be oriented and cooperative,
• be between 18-45 years old,
• To voluntarily agree to participate in the study (signing the Informed Consent Form),
• Repeated cesarean section,
• Cesarean section under spinal anesthesia,
• Not having a risky pregnancy (preeclampsia, gestational diabetes etc.),
• No health problems of the fetus,
• To have given birth by cesarean section between 37-40 weeks,
• To be in the second hour of the postpartum period,
• Not receiving post-op patient-controlled analgesia,
• Not to have smoked or used alcohol during pregnancy,
• No complications in the mother and/or newborn after cesarean section,
• No sensitivity in the area where acupressure will be applied,
• Absence of any systemic or psychiatric diagnosis,
• Absence of active COVID-19 infection.

Exclusion Criteria:

• Lack of consciousness,
• The mother tongue is not Turkish,
• Not oriented and cooperative,
• Not to be between the ages of 18-45,
• Refusal to voluntarily participate in the study (those who did not sign the Informed Consent Form),
• Normal birth or cesarean delivery under general anesthesia,
• Cesarean delivery due to the risk of deterioration of maternal or fetal health,
• Not having had a risky pregnancy (preeclampsia, gestational diabetes, etc.),
• Not giving birth outside 37-40 weeks and by cesarean section,
• Not in the second hour of the postpartum period,
• Receiving post-op patient-controlled analgesia,
• To have used cigarettes and alcohol during pregnancy,
• Sensitivity in the area where acupressure will be applied,
• Presence of any systemic or psychiatric diagnosis,
• Active COVID-19 infection.

In the study, a researcher (T.Ç.Y.) will determine the acupressure and placebo points to be applied to women. However, the researcher (A.A.) who will apply acupressure and placebo acupressure be blinded without knowing whether these points are acupressure or placebo points. Participants will not know that they are in the acupressure or placebo group. Thus, the research will be carried out as a double-blind randomized controlled trial. When the research is completed, the data of the control and study groups (A or B) will be transferred to the computer environment by a researcher independent of the research, and the data will be analyzed by a statistician and the findings will be reported.